Downstream Manufacturing Solutions
-
Advance Lentiviral Purification
2/29/2024
This affinity matrix resin is specifically designed for the purification of VSV-G pseudotyped lentivirus particles from suspension cultivations.
-
Companion Product Solutions For AAV Development
2/26/2024
When optimizing and scaling AAV production, this portfolio of affinity resins may offer you advantages in obtaining high purity and yield in a single step for efficient purification of viral vectors for research applications.
-
Sodium Hydroxide: NaOH 1M In 20 L Flexsafe® Bag
2/21/2024
20L Flexsafe® bags are the most appropriate format and a cGMP manufacturing process using WFI-quality water ensure the highest level of quality for a product.
-
Ready-To-Hydrate Buffers And Media
2/21/2024
Reduce time and contamination risks while gaining consistency from batch to batch. Powder buffers and media prefilled bags are pre-weighed and designed to match requirements for the smaller volumes up to manufacturing scale.
-
Proven Vial Containment That Scales From R&D To Commercial
2/20/2024
Speed up your time to market and reduce your risk of selecting individual components that may not work well together by choosing the Ready Pack containment solution.
-
Purify Specialized mAbs
2/13/2024
High-capacity resin specifically designed to bind to the CH1 region on monoclonal antibodies for simple purification of bispecifics, fusion proteins and other next-generation therapeutics.
-
Simplify mAb Purification With The Right Resin
2/13/2024
Are you seeking a high-capacity, cost-friendly alternative to traditional methods of purification? This agarose-based affinity resin could be your answer to improving mAb purification.
-
Process Development
1/25/2024
EirGenix is a contract development and manufacturing organization that performs high quality and cost-effective services supporting our clients in development, analytical testing, and GMP manufacturing of biopharmaceuticals from pre-clinical to commercial manufacturing
EirGenix has strong process development capabilities in both microbial and mammalian systems to provide our clients process development, process optimization, and process troubleshooting. We have successfully delivered results to meet clients’ requirement in product productivity, product quality, and process cost effectiveness. Our previous project experience includes recombinant proteins, plasmid DNA, fusion proteins, monoclonal antibodies, and biosimilars.
-
cGMP Manufacturing - Mammalian System
1/25/2024
Review how a comprehensive cGMP manufacturing facility is poised to support the development and manufacture of your mammalian cell program.
-
Antibody-Drug Conjugate
1/25/2024
EirGenix provides client-oriented contract development and manufacturing services for biologics, especially monoclonal antibodies and biosimilars. Combining the capabilities of EirGenix’s strategic partner, Formosa Laboratories, Inc, a high potency API manufacturer, we offer integrated services for Antibody Drug Conjugate (ADC) development and manufacturing.